231 related articles for article (PubMed ID: 31105705)
1. Functional Antibody Responses Following Allogeneic Stem Cell Transplantation for
van Zelm MC; Pumar M; Shuttleworth P; Aui PM; Smart JM; Grigg A; Bosco JJ
Front Immunol; 2019; 10():895. PubMed ID: 31105705
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic stem cell transplantation for X-linked agammaglobulinemia using reduced intensity conditioning as a model of the reconstitution of humoral immunity.
Ikegame K; Imai K; Yamashita M; Hoshino A; Kanegane H; Morio T; Kaida K; Inoue T; Soma T; Tamaki H; Okada M; Ogawa H
J Hematol Oncol; 2016 Feb; 9():9. PubMed ID: 26873735
[TBL] [Abstract][Full Text] [Related]
3. An International Survey of Allogeneic Hematopoietic Cell Transplantation for X-Linked Agammaglobulinemia.
Nishimura A; Uppuluri R; Raj R; Swaminathan VV; Cheng Y; Abu-Arja RF; Fu B; Laberko A; Albert MH; Hauck F; Bucciol G; Bigley V; Elcombe S; Kharya G; Pronk CJH; Wehr C; Neven B; Warnatz K; Meyts I; Morio T; Gennery AR; Kanegane H
J Clin Immunol; 2023 Nov; 43(8):1827-1839. PubMed ID: 37454339
[TBL] [Abstract][Full Text] [Related]
4. [Peripheral blood stem cell transplantation from HLA-mismatched unrelated donor or haploidentical donor for the treatment of X-linked agammaglobulinemia].
Nie L; Su T; Yang KT; Zhao L; Hu J; Yang SH; Xu YJ; Fu B
Zhongguo Dang Dai Er Ke Za Zhi; 2020 Aug; 22(8):821-827. PubMed ID: 32800027
[TBL] [Abstract][Full Text] [Related]
5. Treosulfan-based reduced toxicity hematopoietic stem cell transplantation in X-linked agammaglobulinemia: A cost-effective alternative to long-term immunoglobulin replacement in developing countries.
Vellaichamy Swaminathan V; Uppuluri R; Patel S; Melarcode Ramanan K; Ravichandran N; Jayakumar I; Vaidhyanathan L; Raj R
Pediatr Transplant; 2020 Feb; 24(1):e13625. PubMed ID: 31821668
[TBL] [Abstract][Full Text] [Related]
6. A Novel
Han SP; Lin YF; Weng HY; Tsai SF; Fu LS
Front Immunol; 2019; 10():1953. PubMed ID: 31481959
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.
Gürman G; Arat M; Ilhan O; Konuk N; Beksaç M; Celebi H; Ozcan M; Arslan O; Ustün C; Akan H; Uysal A; Koç H
Cytotherapy; 2001; 3(4):253-60. PubMed ID: 12171713
[TBL] [Abstract][Full Text] [Related]
8. Minimal GVHD following in-vitro T cell-depleted allogeneic stem cell transplantation with reduced-intensity conditioning allowing subsequent infusions of donor lymphocytes in patients with hematological malignancies and solid tumors.
Barge RM; Osanto S; Marijt WA; Starrenburg CW; Fibbe WE; Nortier JW; Falkenburg JH; Willemze R
Exp Hematol; 2003 Oct; 31(10):865-72. PubMed ID: 14550801
[TBL] [Abstract][Full Text] [Related]
9. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
10. Case Report: A Case of X-Linked Agammaglobulinemia With High Serum IgE Levels and Allergic Rhinitis.
Cinicola B; Uva A; Leonardi L; Moratto D; Giliani S; Carsetti R; Ferrari S; Zicari AM; Duse M
Front Immunol; 2020; 11():582376. PubMed ID: 33224144
[TBL] [Abstract][Full Text] [Related]
11. Clinical and mutational features of X-linked agammaglobulinemia in Mexico.
García-García E; Staines-Boone AT; Vargas-Hernández A; González-Serrano ME; Carrillo-Tapia E; Mogica-Martínez D; Berrón-Ruíz L; Segura-Mendez NH; Espinosa-Rosales FJ; Yamazaki-Nakashimada MA; Santos-Argumedo L; López-Herrera G
Clin Immunol; 2016 Apr; 165():38-44. PubMed ID: 26960951
[TBL] [Abstract][Full Text] [Related]
12. IgA nephropathy in a child with X-linked agammaglobulinemia: a case report.
Song Y; Sun L; Feng D; Sun Q; Wang Y
BMC Pediatr; 2024 Apr; 24(1):291. PubMed ID: 38689221
[TBL] [Abstract][Full Text] [Related]
13. [A retrospective study of one case of X-linked agammaglobulinemia].
Li DX; Wang XC; Tan SY; Lao SH; Chen ZH; Wang YH; Li FZ; Liang YQ; Wang J
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Dec; 29(12):796-800. PubMed ID: 17327079
[TBL] [Abstract][Full Text] [Related]
14. X-linked agammaglobulinemia associated with B-precursor acute lymphoblastic leukemia.
Hoshino A; Okuno Y; Migita M; Ban H; Yang X; Kiyokawa N; Adachi Y; Kojima S; Ohara O; Kanegane H
J Clin Immunol; 2015 Feb; 35(2):108-11. PubMed ID: 25591849
[TBL] [Abstract][Full Text] [Related]
15. Atypical X-linked agammaglobulinaemia caused by a novel BTK mutation in a selective immunoglobulin M deficiency patient.
Lim LM; Chang JM; Wang IF; Chang WC; Hwang DY; Chen HC
BMC Pediatr; 2013 Sep; 13():150. PubMed ID: 24074005
[TBL] [Abstract][Full Text] [Related]
16. Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicity.
Cull GM; Haynes AP; Byrne JL; Carter GI; Miflin G; Rebello P; Hale G; Waldmann H; Russell NH
Br J Haematol; 2000 Mar; 108(4):754-60. PubMed ID: 10792280
[TBL] [Abstract][Full Text] [Related]
17. Plasma therapy leads to an increase in functional IgA and IgM concentration in the blood and saliva of a patient with X-linked agammaglobulinemia.
Langereis JD; Jacobs JFM; de Jonge MI; van Deuren M
J Transl Med; 2019 May; 17(1):174. PubMed ID: 31122289
[TBL] [Abstract][Full Text] [Related]
18. X-linked agammaglobulinemia in a 10-year-old boy with a novel non-invariant splice-site mutation in Btk gene.
Maekawa K; Yamada M; Okura Y; Sato Y; Yamada Y; Kawamura N; Ariga T
Blood Cells Mol Dis; 2010 Apr; 44(4):300-4. PubMed ID: 20122858
[TBL] [Abstract][Full Text] [Related]
19. Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease?
Radujkovic A; Guglielmi C; Bergantini S; Iacobelli S; van Biezen A; Milojkovic D; Gratwohl A; Schattenberg AV; Verdonck LF; Niederwieser DW; de Witte T; Kröger N; Olavarria E;
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1230-6. PubMed ID: 25797175
[TBL] [Abstract][Full Text] [Related]
20. Mutations in Bruton's tyrosine kinase impair IgA responses.
Mitsuiki N; Yang X; Bartol SJ; Grosserichter-Wagener C; Kosaka Y; Takada H; Imai K; Kanegane H; Mizutani S; van der Burg M; van Zelm MC; Ohara O; Morio T
Int J Hematol; 2015 Mar; 101(3):305-13. PubMed ID: 25589397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
